Not Yet RecruitingNot Applicable

Radiographic Assessment of Bone Gain Following Sinus Lifting With Simultaneous Implant Placement Using Crestal Approach With Membrane Control Technique for Bone Augmentation of Atrophied Maxillary Posterior Ridge

10 participantsStarted 2024-06-01

Plain-language summary

This study aims to evaluate the quantity and quality of the native and the newly bone around dental implants that's simultaneously installed with sinus lifting

Who can participate

Age range18 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients required dental implant treatment in the posterior maxilla, in the premolar and molar regions ( both sexes).
✓. Residual bone height 4-8mm in the estimated implant positions.
✓. The bone width of the alveolar ridge is at least 5mm in estimated implant positions.
✓. The edentulous ridges are covered with optimal thickness of mucoperiosteum.

Exclusion criteria

✕. Patients with a systemically diseases or inflammation whether local or generalized.
✕. Patients with bleeding disorders.
✕. Subjected to irradiation in the head and neck area less than 1 year before implantation.
✕. Poor oral hygiene and motivation.
✕. Pregnant or nursing.
✕. Severe bruxism or clenching.
✕. Active infection or severe inflammation in the area intended for implant placement.
✕. Unable to open mouth sufficiently to accommodate the surgical tooling.

What they're measuring

Cone beam computed tomography (CBCT) bone height formation around dental implants

Timeframe: Patients will be evaluated after 3 days and weekly for the first month and then once monthly up to 4 months for signs of dehiscence. then cone-beam computed tomography 4 months postoperatively to calculate the amount of vertical bone gain.

Trial details

NCT IDNCT06446687

SponsorCairo University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-10-01

View on ClinicalTrials.gov More Implant Site Reaction trials